INS and diabetes mellitus: To our knowledge, REPOSE is the firstlarge trial in adults with type one diabetes that provides evidence on pumps versus MDI(in which both long-acting and short-acting analogue insulins are used) that providesequivalent diabetes education to both trial arms.